BREA, Calif. - Envista Holdings Corporation (NYSE: NYSE:NVST), a global provider of dental products and services, has announced it will release its financial results for the fourth quarter of 2023 on February 7, 2024. Following the release, the company will host a conference call at 2:00 PM PT on the same day to discuss the results.
Investors and interested parties can listen to the live webcast of the call on Envista's website under the "Investors" section. Additionally, a replay of the webcast will be made available shortly after the call concludes and will be accessible for one year.
For direct access to the conference call, participants in the U.S. can dial 800-225-9448 and international callers can dial +1 203-518-9708, entering the conference ID #7305894 a few minutes before the start time.
Envista will also provide an earnings press release, a slide presentation, and other materials related to the call on its website prior to the conference call.
Envista Holdings Corporation is recognized for its extensive family of over 30 dental brands, which include Nobel Biocare, Ormco, DEXIS, and Kerr. The company's mission is to collaborate with dental professionals to enhance patient care with its broad range of consumables, solutions, technology, and services. Their portfolio addresses various clinical needs for the diagnosis, treatment, and prevention of dental conditions, as well as improving patients' smile aesthetics.
The company operates with a foundation of the Envista Business System (EBS) methodology, an experienced leadership team, and a culture focused on continuous improvement, innovation, and customer satisfaction. Envista stands as one of the largest dental product companies globally, holding significant market positions in several of the most attractive segments of the dental industry.
This announcement of the upcoming earnings call is based on a press release statement from Envista Holdings Corporation.
InvestingPro Insights
As Envista Holdings Corporation gears up to share its latest financial results, investors may be seeking additional insights to gauge the company's performance. According to InvestingPro, Envista's industry peer, W.P. Carey Inc. (NYSE: WPC), showcases a robust financial health and growth potential. InvestingPro Tips highlight W.P. Carey's high earnings quality, with free cash flow exceeding net income and a track record of consistently increasing earnings per share. Notably, W.P. Carey has also maintained dividend payments for an impressive 26 consecutive years. These attributes may interest investors looking for stability and growth within the same sector.
Delving into InvestingPro Data, W.P. Carey's market capitalization stands at $14.55 billion, with a P/E ratio of 18.33, indicating a potentially favorable valuation relative to its earnings. The company's revenue has grown by 22.15% over the last twelve months as of Q3 2023, and its gross profit margin is an impressive 92.39%, reflecting strong operational efficiency. Additionally, W.P. Carey has seen a strong return over the last three months, with a price total return of 26.92%.
Investors considering the broader dental products and services market may find these metrics and insights from W.P. Carey relevant when evaluating Envista's upcoming earnings release. For those looking to delve deeper, a subscription to InvestingPro now comes with a special Cyber Monday sale, offering a discount of up to 60%. Plus, use coupon code ProW345 to get an additional 10% off a 2-year InvestingPro+ subscription. With 11 more InvestingPro Tips listed on their platform, investors can access a wealth of data to inform their investment decisions.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.